Analytical Data
-
Gene name
RIHB
- Application
-
Alternative Names
RIHB;yeiK;Pyrimidine-specific ribonucleoside hydrolase RihB
-
Species
E.coli
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P33022
-
Expression Region
1-313aa
-
AA Sequence
MEKRKIILDC DPGHDDAIAI MMAAKHPAID LLGITIVAGN QTLDKTLING LNVCQKLEIN VPVYAGMPQP IMRQQIVADN IHGETGLDGP VFEPLTRQAE STHAVKYIID TLMASDGDIT LVPVGPLSNI AVAMRMQPAI LPKIREIVLM GGAYGTGNFT PSAEFNIFAD PEAARVVFTS GVPLVMMGLD LTNQTVCTPD VIARMERAGG PAGELFSDIM NFTLKTQFEN YGLAGGPVHD ATCIGYLINP DGIKTQEMYV EVDVNSGPCY GRTVCDELGV LGKPANTKVG ITIDTDWFWG LVEECVRGYI KTH
-
Molecular Weight
33.7 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
RIHB, or Recombinant Interleukin-1β Homolog, is a synthetic protein that has garnered attention in the field of immunology and biopharmaceutical research due to its potential therapeutic applications. Interleukin-1β (IL-1β) is a crucial cytokine involved in the inflammatory response, and its dysregulation is associated with various diseases, including autoimmune disorders, inflammatory diseases, and certain cancers. The recombinant form of this protein, RIHB, allows for comprehensive studies on its structure-function relationships and biological activities, facilitating the understanding of its mechanism in immune system modulation. Advances in recombinant DNA technology have enabled the precise manipulation and expression of RIHB in various biological systems, thus supporting investigations into its roles in cell signaling pathways and its interactions with other immune components. Additionally, RIHB can serve as a valuable tool in drug development, offering insights into novel therapeutic strategies for diseases characterized by chronic inflammation. The growing body of research surrounding RIHB underscores its significance in both basic and applied sciences, aiming to elucidate its therapeutic potential and pave the way for innovative treatments that can better manage inflammatory and autoimmune conditions.











